Insider Trading Spectrum: From Small-Scale Buddies To “Most Lucrative Inside Tip Of All Time”
Executive Summary
SEC was able to trace trading patterns and relationships between former high school friends back to employees at Celgene and Sanofi; SEC also filed a complaint against a former hedge fund manager who made a record $276 million profit trading on insider information about Alzheimer’s disease drug bapineuzumab.